RVL Pharmaceuticals PLC

RVLP Healthcare Biotechnology

RVL Pharmaceuticals PLC’s revenue for fiscal 2022 (year ended December 2022) was $49.7 million.

Market cap
$14.1M
P/E
0.0×
Fwd P/E
−4.8×
Dividend yield
—
F-score
3/9
Altman Z
n/a
Beneish M
−1.83
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22
Total current assets
94.21 114.83 172.36 172.63 173.15 59.38 56.98
Total non-current assets
884.29 804.91 623.26 290.63 197.80 85.29 71.54
Total Assets
978.50 919.74 795.62 463.26 370.95 144.67 128.51
Total current liabilities
117.83 124.68 114.00 75.94 55.78 20.11 19.72
Total non-current liabilities
395.46 359.28 297.78 272.61 221.31 47.83 57.69
Total liabilities
513.30 483.96 411.78 348.55 277.09 67.94 77.42
Common Equity (Total)
465.21 435.78 383.85 114.71 93.86 76.73 51.09
Shareholders Equity (Total)
465.21 435.78 383.85 114.71 93.86 76.73 51.09
Total Debt
328.91 320.66 268.72 270.18 220.74 46.21 56.95

Show all line items

In millions of $ except per-share values · columns are period end dates